84 related articles for article (PubMed ID: 26805272)
21. [The prognostic influence of D2 lymphadenectomy with para-aortic lymph nodal dissection for gastric cancer in N3 stage].
Liang YX; Liang H; Ding XW; Wang XN; Zhang L; Wu LL; Liu HG; Jiao XG
Zhonghua Wai Ke Za Zhi; 2013 Dec; 51(12):1071-6. PubMed ID: 24499714
[TBL] [Abstract][Full Text] [Related]
22. A multicentric Western analysis of prognostic factors in advanced, node-negative gastric cancer patients.
Baiocchi GL; Tiberio GA; Minicozzi AM; Morgagni P; Marrelli D; Bruno L; Rosa F; Marchet A; Coniglio A; Saragoni L; Veltri M; Pacelli F; Roviello F; Nitti D; Giulini SM; De Manzoni G
Ann Surg; 2010 Jul; 252(1):70-3. PubMed ID: 20562605
[TBL] [Abstract][Full Text] [Related]
23. Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes.
Xu DZ; Geng QR; Long ZJ; Zhan YQ; Li W; Zhou ZW; Chen YB; Sun XW; Chen G; Liu Q
Ann Surg Oncol; 2009 Feb; 16(2):319-26. PubMed ID: 19050970
[TBL] [Abstract][Full Text] [Related]
24. Outcome in relation to numbers of nodes harvested in lymph node-positive gastric cancer.
Deng JY; Liang H; Sun D; Pan Y; Zhang RP; Wang BG; Zhan HJ
Eur J Surg Oncol; 2009 Aug; 35(8):814-9. PubMed ID: 19111430
[TBL] [Abstract][Full Text] [Related]
25. Surgical outcome of node-positive early gastric cancer with particular reference to nodal status.
Kikuchi S; Sato M; Katada N; Sakuramoto S; Kobayashi N; Shimao H; Sakakibara Y; Kakita A
Anticancer Res; 2000; 20(5C):3695-700. PubMed ID: 11268441
[TBL] [Abstract][Full Text] [Related]
26. Problems in the N-classification of the new 1997 UICC TNM stage classification for gastric cancer: an analysis of over 10 years' outcome of Japanese patients.
Nio Y; Yamasawa K; Yamaguchi K; Itakura M; Omori H; Koike M; Kitamura Y; Tsuji M; Endo S; Ogo Y; Yano S; Sumi S
Anticancer Res; 2003; 23(1B):697-705. PubMed ID: 12680170
[TBL] [Abstract][Full Text] [Related]
27. Changes in postoperative recurrence and prognostic risk factors for patients with gastric cancer who underwent curative gastric resection during different time periods.
Kim DH; Kim SM; Hyun JK; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
Ann Surg Oncol; 2013 Jul; 20(7):2317-27. PubMed ID: 23677605
[TBL] [Abstract][Full Text] [Related]
28. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
[TBL] [Abstract][Full Text] [Related]
29. [A case of gastric cancer showing response to first-line XP regimen after lymph node recurrence during the administration of S-1 as postoperative adjuvant chemotherapy].
Mihara K; Yamashiro N; Nishiya S; Kemmochi T; Ito Y; Egawa T; Nagashima A
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2358-60. PubMed ID: 25731522
[TBL] [Abstract][Full Text] [Related]
30. Improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer.
Eom BW; Joo J; Kim YW; Reim D; Park JY; Yoon HM; Ryu KW; Lee JY; Kook MC
Surgery; 2014 Mar; 155(3):408-16. PubMed ID: 24287148
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of pre-operative chemotherapy with docetaxel, cisplatin, and S-1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para-aortic lymph nodes.
Oyama K; Fushida S; Kinoshita J; Makino I; Nakamura K; Hayashi H; Nakagawara H; Tajima H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Tani T; Fujimura T; Ohta T
J Surg Oncol; 2012 May; 105(6):535-41. PubMed ID: 22006649
[TBL] [Abstract][Full Text] [Related]
32. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
[TBL] [Abstract][Full Text] [Related]
33. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
Nashimoto A; Nakajima T; Furukawa H; Kitamura M; Kinoshita T; Yamamura Y; Sasako M; Kunii Y; Motohashi H; Yamamoto S;
J Clin Oncol; 2003 Jun; 21(12):2282-7. PubMed ID: 12805327
[TBL] [Abstract][Full Text] [Related]
34. [Analysis of splenic hilar lymph node metastasis in advanced gastric cancer and dissection techniques].
Zhang CH; Wu AW; Li ZY; Zhang LH; Bu ZD; Wu XJ; Zong XL; Li SX; Shan F; Ji JF
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Aug; 14(8):589-92. PubMed ID: 21866448
[TBL] [Abstract][Full Text] [Related]
35. Proximal gastric cancer: lymph node metastatic patterns according to different T stages dictate surgical approach.
Song W; Liu Y; Ye J; Peng J; He W; Chen J; Chen C; He Y
Chin Med J (Engl); 2014; 127(23):4049-54. PubMed ID: 25430447
[TBL] [Abstract][Full Text] [Related]
36. Radical Gastrectomy: Still the Cornerstone of Curative Treatment for Gastric Cancer in the Perioperative Chemotherapy Era-A Single Institute Experience over a Decade.
Kanhere H; Goel R; Finlay B; Trochsler M; Maddern G
Int J Surg Oncol; 2018; 2018():9371492. PubMed ID: 29568650
[TBL] [Abstract][Full Text] [Related]
37. Is gastrectomy mandatory for all residual or recurrent gastric cancer following endoscopic resection? A large-scale Korean multi-center study.
Song KY; Hyung WJ; Kim HH; Han SU; Cho GS; Ryu SW; Lee HJ; Kim MC;
J Surg Oncol; 2008 Jul; 98(1):6-10. PubMed ID: 18521830
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.
Di Costanzo F; Gasperoni S; Manzione L; Bisagni G; Labianca R; Bravi S; Cortesi E; Carlini P; Bracci R; Tomao S; Messerini L; Arcangeli A; Torri V; Bilancia D; Floriani I; Tonato M; ; Dinota A; Strafiuso G; Corgna E; Porrozzi S; Boni C; Rondini E; Giunta A; Monzio Compagnoni B; Biagioni F; Cesari M; Fornarini G; Nelli F; Carboni M; Cognetti F; Enzo MR; Piga A; Romiti A; Olivetti A; Masoni L; De Stefanis M; Dalla Mola A; Camera S; Recchia F; De Filippis S; Scipioni L; Zironi S; Luppi G; Italia M; Banducci S; Pisani Leretti A; Massidda B; Ionta MT; Nicolosi A; Canaletti R; Biscottini B; Grigniani F; Di Costanzo F; Rovei R; Croce E; Carroccio R; Gilli G; Cavalli C; Olgiati A; Pandolfi U; Rossetti R; Natalini G; Foa P; Oldani S; Bruno L; Cascinu S; Catalano G; Catalano V; Lungarotti F; Farris A; Sarobba MG; Trignano M; Muscogiuri A; Francavilla F; Figoli F; Leoni M; Papiani G; Orselli G; Antimi M; Bellini V; Cabassi A; Contu A; Pazzola A; Frignano M; Lastraioli E; Saggese M; Bianchini D; Antonuzzo L; Mela M; Camisa R
J Natl Cancer Inst; 2008 Mar; 100(6):388-98. PubMed ID: 18334706
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors and recurrence pattern in node-negative advanced gastric cancer.
Lee IS; Yook JH; Kim TH; Kim HS; Kim KC; Oh ST; Kim BS
Eur J Surg Oncol; 2013 Feb; 39(2):136-40. PubMed ID: 23148932
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of metastatic lymph nodes ratio in patients with gastric adenocarcinoma after curative gastrectomy.
Zhang M; Wang J; Shi W; Chen W; Li W; Shu Y; Liu P; Lu K
Chin Med J (Engl); 2014; 127(10):1874-8. PubMed ID: 24824248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
